Recent advances in genetics and molecular biology have allowed researchers to identify genes and molecules associated with particular human diseases. This knowledge has led to the development of more effective therapies for these diseases. Examples include new treatments for breast cancer, lung cancer, asthma, multiple sclerosis, and rheumatoid arthritis.
We have only begun to investigate the genetics and molecular biology of canine diseases, but based on advances in human medicine, a great opportunity exists to make similar advances in treating canine diseases as well. To accomplish this, The Ohio State University college of Veterinary Medicine established a biospecimen repository to collect samples from animals affected by these diseases so that the genetics and molecular biology can be more closely studied.
The Veterinary Biospecimen Repository collects samples of tumors and normal tissue and stores these tissues under controlled conditions for future use by multiple investigators. Following established collection guidelines for sample collection and processing, tissues are collected and archived only after receiving consent from the owners. This repository has been providing samples to researchers at The Ohio State University , Nationwide Children's Hospital, other universities and research institutes resulting in the identification of new targets for therapy in osteosarcoma, melanoma, lymphoma, and pulmonary carcinoma common to both humans and canines. As a result, these efforts have generated several new research opportunities that will benefit human and animal patients.
The Veterinary Biospecimen Repository represents a remarkable resource that continues to assist investigators as they strive to develop new prevention and treatment strategies for both animals and people with a variety of illnesses.